The sale is small in absolute and relative terms, but the pattern of recent sales by a former officer (7,064 shares on June 4 and 45,481 shares on May 8) suggests ongoing portfolio liquidation. Monitor for additional Form 4 filings or a larger Form 144 that could signal a more significant divestment. No immediate price impact expected.
Price Chart
Executive Summary
Former officer Sandip Kapadia filed a Form 144 notice of intent to sell 2,101 shares of Harmony Biosciences (HRMY) with an estimated aggregate market value of approximately $69,504. The shares are to be sold through Morgan Stanley Smith Barney and were acquired via exercise of options under a registered plan. This is a relatively small sale relative to Kapadia's prior reported holdings and the company's $1.9B market cap, but as a former officer filing an intent to sell, it warrants monitoring.
Key Facts
- Form 144 filed by Sandip Kapadia, a former officer of Harmony Biosciences Holdings, Inc.
- Proposed sale of 2,101 shares of common stock with an estimated aggregate market value of $69,504.02.
- Shares to be sold through Morgan Stanley Smith Barney LLC Executive Financial Services.
- Shares acquired via exercise of options under a registered plan on June 5, 2026.
- Kapadia previously sold 7,064 shares on June 4, 2026, and 45,481 shares on May 8, 2026.
- The filing is an advance notice of intent to sell; the sale may not be completed.
Financial Impact
Proposed sale of 2,101 shares valued at approximately $69,504, representing a small fraction of the company's $1.9B market cap.
Risk Factors
- Insider selling by a former officer may signal lack of confidence or personal liquidity needs, though the amount is small.
- The filing is an intent to sell; the actual sale may not occur, reducing the signal value.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001950047-26-005696 |
| Document: 0001950047-26-005696-index.html | 0001950047-26-005696 |
| Document: 0001950047-26-005696.txt | 0001950047-26-005696 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 4, 2026 8w ago | 8-K | $38.78 $39.52 | ▲ +1.91% | ▲ +2.01% | $40.53 (+4.53%) |
Aug 4, 2026 8w ago | Press Release | $38.78 $39.52 | ▲ +1.91% | ▲ +2.01% | $40.53 (+4.53%) |
Jul 16, 2026 11w ago | 8-K | $33.53 $35.80 | ▲ +6.77% | ▲ +8.44% | $40.53 (+20.89%) |
Jun 30, 2026 13w ago | 144 | $36.00 $38.26 | ▼ −6.28% | ▼ −6.02% | $40.53 (−12.60%) |
Jun 24, 2026 14w ago | 144 | $34.13 $36.00 | ▼ −5.48% | ▼ −3.92% | $40.53 (−18.77%) |
Jun 9, 2026 16w ago | 144 | $35.48 $33.83 | ▼ −4.65% | ▼ −8.08% | $40.53 (+14.25%) |
Jun 5, 2026 16w ago | 144 | $32.39 $34.18 | ▲ +5.53% | ▲ +3.41% | $40.53 (+25.15%) |
May 19, 2026 19w ago | 3 | $30.44 $30.76 | ▲ +1.05% | ▼ −1.25% | $40.53 (+33.16%) |
May 7, 2026 21w ago | 8-K | $31.42 $30.83 | ▼ −1.88% | ▼ −3.38% | $40.53 (+29.01%) |
Apr 14, 2026 24w ago | 8-K | $29.29 $32.14 | ▲ +9.73% | ▲ +8.34% | $40.53 (+38.39%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access